20250527_SILO_Laporan Informasi dan Fakta Material_31889849_lamp2.pdf

Key Achievements and Strategic Initiatives

Siloam is proud to announce the successful operation of the Da Vinci Xi Robotic Surgery at Siloam
Hospitals Kebon Jeruk. As part of this achievement, two robot-assisted surgeries have been performed:
a Radical Prostatectomy and a Myomectomy combined with Salpingo-Oophorectomy. This milestone
reflects Siloam’s commitment to delivering advanced, high-quality care and strengthens Siloam’s position
as leader in healthcare innovation in Indonesia.

Additionally, Siloam successfully held the 5th Oncology Summit, attended by over 700 participants,
including 11 international and 89 national speakers covering 24 subspecialities in Oncology. This summit
featured symposiums, workshops, and poster competition, reflecting Siloam’s ongoing commitment to
advancing cancer care and medical education in Indonesia.

Siloam is also expanding its revenue stream by focusing on healthcare innovation. One of its key initiatives
includes the successful launch of Stroke Ready hospitals across 12 Siloam Hospitals. These facilities are
designed to provide rapid and specialized stroke care, supported by internationally recognized protocols
through the WSO Angels Awards. Each of these hospitals equipped with 24/7 specialist availability, a
trained multidisciplinary stroke team, advanced medical technology, and an integrated rapid response
system.

Furthermore, Siloam has opened the Sport and Medicine Centre at Siloam Hospitals Mampang to cater
sports-related medical needs. This center is equipped with cutting-edge technology and services,
including Bone Mineral Density analysis, Stem Cell Treatment, and a range of other advanced medical
offerings.

Commitment to Sustainability (ESG)

Siloam has published its 2024 Sustainability Report as a demonstration of its commitment to creating a
positive impact on the environment and society. Under the environmental pillar, Siloam has achieved ISO
14001 certification and made tangible progress in its decarbonization plan, including a 2% reduction in
waste generation intensity, a 10% decrease in electricity consumption intensity, and a 2.9% reduction in
Scope 1 and 2 emissions intensity. In the social pillar, Siloam continues to offer scholarships for medical
professionals and has expanded the reach of key initiatives such as the SELANGKAH (Spirit to Fight Cancer)
program and the Papua Clinic, which have collectively served over 40,000 people across various regions
in Indonesia.

Siloam is also committed to achieving Net Zero by 2060, in alignment with Indonesia’s national target for
Net Zero Emissions in the same year. This commitment forms part of Siloam’s long-term strategy to build
a more sustainable and responsible healthcare system.

Remarks from Siloam’s President Director:

Siloam’s President Director, Mr. David Utama, commented on the results: “Siloam continues to
strengthen its position as one of Indonesia’s leading healthcare providers while actively positioning itself
to become a regional leader in Southeast Asia. Despite challenges in the healthcare sector, the company
has demonstrated strong execution of its strategic initiatives, enhancing clinical capabilities and
expanding its range of services to meet evolving community needs. With our commitment to exceptional
patient care, Siloam also focuses on optimizing hospital operations to ensure long-term financial
resilience, operational excellence, and sustainable growth."

For more information, please contact:
Vivian Chandra
Investor Relations
Siloam Hospitals Group
vivian.chandra@siloamhospitals.com


About Siloam Hospitals Group

PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed
to providing high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages
and operates 41 hospitals, consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the
islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also
operates 73 Siloam Clinics.

Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national
scale based on Godly compassion which is the basis for Siloam Hospitals to respond to the dynamic social
transformation in Indonesia. Siloam Hospitals' mission is to be the trusted choice for world-class holistic healthcare,
health education and research.

Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is
an international accreditation agency based in the United States that focuses on improving the quality of health
care and patient safety.

For more information about Siloam Hospitals, visit www.siloamhospitals.com.

Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not
intended for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is
given regarding the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our
opinions as of this date and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party
due to part or all the contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not
responsible for any mistakes, omissions, omissions or inaccuracies that can happen.

Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain
words such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities
that are different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the
economic, social and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens
in Indonesia, including regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest
rate development, capital costs and capital availability; anticipated demand and supply prices related to our health services and related capital
expenditures and other investments; construction costs; availability of health services; competition from companies and other locations; changes
in customer demand; changes in operational costs, including employee salaries, wages and training, changes in public and government policies;
our ability to stay competitive; financial conditions, business strategies and plans and targets set by our management for future work;
procurement of future income; compliance with environmental and remediation regulations. If, among other things, one or more of the risks or
uncertainties mentioned above occur, the actual results may differ materially than predicted, anticipated or projected. But not limited, capital
costs can increase, projects can be postponed and anticipated increases in production, capacity or implementation may not all occur. Although
we believe that our management's expectations expressed in predictive statements are reasonable based on the information we have now, we
cannot provide guarantees that these expectations can become reality. You should not depend on these statements immediately. However,
these statements apply only to the date they were stated, and we are not responsible for making updates or revisions, even if new information,
new events or anything is available.